Correlation Between Iteos Therapeutics and Unit

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Unit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Unit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Unit Corporation, you can compare the effects of market volatilities on Iteos Therapeutics and Unit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Unit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Unit.

Diversification Opportunities for Iteos Therapeutics and Unit

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Iteos and Unit is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Unit Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unit and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Unit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unit has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Unit go up and down completely randomly.

Pair Corralation between Iteos Therapeutics and Unit

Given the investment horizon of 90 days Iteos Therapeutics is expected to generate 1.31 times more return on investment than Unit. However, Iteos Therapeutics is 1.31 times more volatile than Unit Corporation. It trades about 0.13 of its potential returns per unit of risk. Unit Corporation is currently generating about 0.15 per unit of risk. If you would invest  841.00  in Iteos Therapeutics on May 17, 2025 and sell it today you would earn a total of  170.00  from holding Iteos Therapeutics or generate 20.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Iteos Therapeutics  vs.  Unit Corp.

 Performance 
       Timeline  
Iteos Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Iteos Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Iteos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Unit 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Unit Corporation are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Unit exhibited solid returns over the last few months and may actually be approaching a breakup point.

Iteos Therapeutics and Unit Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iteos Therapeutics and Unit

The main advantage of trading using opposite Iteos Therapeutics and Unit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Unit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unit will offset losses from the drop in Unit's long position.
The idea behind Iteos Therapeutics and Unit Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk